THE EFFECT OF ENDOVASCULAR BAROREFLEX AMPLIFICATION ON SYMPATHETIC NERVE ACTIVITY IN PATIENTS WITH RESISTANT HYPERTENSION: A PROOF-OF-MECHANISM STUDY

Objective:Endovascular baroreflex amplification (EVBA) is a novel device-based therapy that has been shown to lower blood pressure (BP) in patients with resistant hypertension (RHTN) in an uncontrolled first-in-human study. It is postulated that EVBA lowers BP, at least in part, by inhibiting muscle